11.1 Reimbursement Methodologies
Key Takeaways
- Fee-for-service pays for discrete units of care and tends to reward volume; prospective and capitation models shift financial risk toward providers.
- Managed care uses networks, utilization management, and risk arrangements to control cost and access; executives must understand HMO, PPO, and related structures.
- Medicare and Medicaid set national and state program rules that dominate payer mix, pricing floors, and documentation standards for most U.S. providers.
- Value-based payment links revenue to quality, cost, and outcomes (shared savings, bundles, pay-for-performance) and requires care redesign—not only coding skill.
- Reimbursement methodology choice drives clinical documentation, denials risk, care pathways, capacity planning, and contract strategy across the enterprise.
Reimbursement Methodologies
Quick Answer: Reimbursement methodologies are the rules that determine how and how much providers are paid for care. On the FACHE Board of Governors exam (Finance F4), you must distinguish fee-for-service, prospective payment, managed care, national/state programs (especially Medicare and Medicaid), and value-based models—and explain their ramifications for cost, quality, access, documentation, and leadership decisions.
Revenue is not a single “rate.” It is a portfolio of payment methods negotiated with commercial plans, set by public programs, and increasingly conditioned on quality and total cost of care. Executives who only understand charges miss how risk, incentives, and cash timing actually work.
Fee-for-Service (FFS) and Its Ramifications
Under fee-for-service, the provider bills for discrete units—visits, procedures, tests, days, or CPT/HCPCS codes—and is paid a fee for each unit allowed by the payer. Variants include percent of charges, fee schedules, and usual, customary, and reasonable (UCR) approaches. FFS remains common in ambulatory specialty care, many commercial outpatient contracts, and parts of professional billing even when facilities are under prospective systems.
Ramifications of FFS:
| Dimension | Typical effect |
|---|---|
| Volume | Incentive to increase units of service |
| Care coordination | Weak natural incentive to reduce unnecessary care across settings |
| Cash flow | Payment follows claims; denials and coding accuracy matter immediately |
| Cost control for payers | Harder without utilization management or network design |
| Provider margin | Sensitive to mix, coding depth, and payer fee schedules |
Trap: Equating “more revenue” with “better strategy.” Under pure FFS, high volume of low-value services can grow revenue while harming quality metrics that later determine value-based bonuses or public reputation.
Scenario — Imaging expansion. A hospital proposes a second CT scanner because outpatient volume is growing. Under FFS contracts, the business case may look strong. Under a capitated or shared-savings arrangement covering the same population, more imaging may increase cost without increasing revenue—and may even reduce shared savings. The methodology determines whether the capital project is a growth engine or a cost center.
Prospective Payment Systems
Prospective payment sets a payment (or rate framework) in advance based on classification of the case or encounter, not on every itemized charge. Classic examples:
- Inpatient prospective payment (IPPS) using MS-DRGs (Medicare Severity Diagnosis-Related Groups)—payment for the inpatient stay largely determined by diagnosis, procedures, and severity coding
- Outpatient prospective payment (OPPS) using APCs (Ambulatory Payment Classifications) for hospital outpatient services
- Post-acute systems (historically RUGs; skilled nursing and other settings use evolving case-mix models such as PDPM-style constructs) that pay based on patient characteristics and care categories rather than pure per diem FFS
Ramifications of prospective payment:
- Providers bear more cost risk within the episode or stay; longer stays or higher supply cost do not automatically raise payment
- Clinical documentation integrity (CDI) and accurate coding become financial systems, not only compliance chores
- Incentives favor efficient length of stay, care pathways, and reduced avoidable complications (within quality and safety constraints)
- Outlier policies, transfers, and short-stay rules create technical traps executives must understand at a conceptual level
Exam framing: Prospective payment does not mean the organization is “paid the same regardless of quality.” Quality and compliance failures still create readmission penalties, denials, audits, and reputational harm. It means the base rate is largely fixed by classification, so cost discipline inside that rate is management’s job.
Capitation and Global Risk
Capitation pays a fixed amount per member per month (PMPM) (or similar covered-life metric) for a defined benefit package, regardless of how many services that member uses in the period (subject to contract carve-outs). Related ideas include global budgets and full-risk arrangements for defined populations.
Ramifications:
- Incentive shifts toward prevention, primary care access, care management, and avoidance of unnecessary high-cost utilization
- Underutilization becomes an ethical and quality risk if controls are too aggressive—Fellows must balance margin with appropriate care
- Actuarial skill, attribution rules, and stop-loss protection become executive topics
- Data infrastructure for utilization and risk stratification becomes a core asset
Managed Care Structures
Managed care is not one payment method; it is a set of tools that organize networks, benefits, utilization, and financial risk. Common product types:
| Model | Core idea | Executive implication |
|---|---|---|
| HMO | Closed or tightly managed network; often stronger gatekeeping and utilization controls | Credentialing, referral management, medical management partnerships |
| PPO | Broader network; higher member cost-sharing out of network | Volume depends on network inclusion and competitive rates |
| POS / hybrid | Member choice with differential benefits | More complex benefit design and billing education |
| Medicare Advantage / managed Medicaid | Public beneficiaries enrolled in managed plans | Dual public rules + plan medical policy; major growth area |
Managed care tools include prior authorization, concurrent review, case management, formularies, and narrow networks. From a finance view, contracts may still use FFS rates, DRG case rates, per diems, capitation, or quality incentives—or combinations.
Scenario — Prior authorization surge. A commercial payer tightens imaging prior auth. Even if unit rates are unchanged, cash and volume fall if denials rise or patients delay care. Operations, revenue cycle, and clinical leaders must redesign order sets and documentation—not only appeal denials after the fact.
National and State Programs: Medicare and Medicaid
Medicare is the federal program primarily for age 65+, certain disabilities, and ESRD. Conceptual parts executives must know:
- Part A — hospital inpatient, skilled nursing (with limits), hospice, some home health
- Part B — physician and outpatient services, durable medical equipment
- Part C (Medicare Advantage) — private plans administering Medicare benefits, often with supplemental benefits and different network rules
- Part D — prescription drug coverage
Medicare payment systems (IPPS, OPPS, physician fee schedule concepts, post-acute rules) set benchmarks that commercial payers often reference. Quality programs, readmission reduction, value-based purchasing, and documentation requirements create both opportunity and penalty risk.
Medicaid is a joint federal–state program for low-income and other eligible populations. States differ in eligibility, benefits, provider rates, and the share of beneficiaries in managed Medicaid. Ramifications include:
- Lower average payment rates in many markets (payer-mix sensitivity)
- High behavioral health, maternity, and long-term services utilization patterns
- State budget and policy volatility as a strategic risk
- Growing importance of managed care organization (MCO) contracting and quality metrics
Other public or quasi-public arrangements (CHIP, VA, TRICARE, workers’ compensation, state programs) matter by market; exam emphasis is on Medicare/Medicaid mechanics and incentives rather than memorizing every state fee schedule.
Value-Based Payment
Value-based models link payment to quality, outcomes, patient experience, and/or cost rather than volume alone. Common forms:
- Pay-for-performance (P4P) — bonuses or penalties tied to quality metrics
- Shared savings (e.g., accountable care-style constructs) — providers share in savings if quality gates are met
- Bundled payments — single payment (or target) for an episode across providers
- Downside risk / advanced models — providers may owe money if costs exceed targets
Ramifications for executives:
- Need for care redesign, post-acute network management, and reduction of avoidable utilization
- Investment in analytics, care management, and social needs partnerships
- Alignment of physician compensation with value metrics without creating ethical conflicts
- Contract literacy: attribution, risk adjustment, quality gates, and stop-loss
Trap: Treating value-based payment as a revenue-cycle coding project only. Coding matters, but durable performance requires clinical operations change—pathways, transitions, primary care access, and specialty appropriateness.
Executive Synthesis: Methodology Portfolio
Most organizations run a mix: Medicare IPPS/OPPS, Medicaid FFS or managed care, commercial FFS and case rates, and a growing share of value-based or Medicare Advantage contracts. Leadership tasks include:
- Modeling payer mix and contribution margin by service line
- Negotiating contracts with clear unit definitions, carve-outs, and quality terms
- Building CDI, denials prevention, and utilization review as integrated systems
- Educating boards that “growth” under value models may mean better total cost and outcomes, not always more inpatient volume
Exam-ready summary: Know FFS (volume incentives), prospective payment (fixed case/encounter rates and cost risk), capitation (PMPM population risk), managed care tools and products, Medicare/Medicaid program roles, and value-based designs—then always ask what behavior the method rewards and what that means for quality, access, and margin.
Under a pure fee-for-service reimbursement methodology, which incentive is MOST characteristic?
A hospital is paid a predetermined MS-DRG amount for a Medicare inpatient stay regardless of most itemized charges during that stay. This BEST illustrates which methodology?
Leadership is evaluating a joint replacement service line under a bundled-payment contract that includes post-acute care. Which action BEST fits the financial incentives of that methodology?